LUMITHERA
LumiThera is a medical device company focused on LED and laser treatments for acute and chronic ocular disease. The company is developing solutions to prevent vision loss and blindness, improve visual function, and stop or slow the progression of blinding diseases of the eye. They delivering photobiomodulation (PBM) treatment for ocular disorders and diseases. LumiThera also focused on treating patients affected by dry age-related macular degeneration. The company’s expertise is in the application of photobiomodulation (PBM), using non-invasive light-emitting diodes (LED) for acute and chronic ocular diseases and disorders. The company was founded in 2013 and is headquartered in Poulsbo, Washington, United States.
LUMITHERA
Social Links:
Industry:
Health Care Manufacturing Medical Medical Device
Founded:
2013-01-01
Address:
Poulsbo, Washington, United States
Country:
United States
Website Url:
http://www.lumithera.com
Total Employee:
11+
Status:
Active
Contact:
+44-2076601516
Total Funding:
35.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Apnimed
Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-07-26 | MacuLogix | MacuLogix acquired by LumiThera | N/A |
| 2021-11-11 | Diopsys | Diopsys acquired by LumiThera | N/A |
Investors List
Serengeti Asset Management
Serengeti Asset Management investment in Debt Financing - LumiThera
Leste Clearway
Leste Clearway investment in Debt Financing - LumiThera
Celeste Management
Celeste Management investment in Series C - LumiThera
Nikon
Nikon investment in Series C - LumiThera
Keiretsu Capital
Keiretsu Capital investment in Series C - LumiThera
WaterStart Capital
WaterStart Capital investment in Series C - LumiThera
Nikon
Nikon investment in Series C - LumiThera
WaterStart Capital
WaterStart Capital investment in Series C - LumiThera
WaterStone Capital
WaterStone Capital investment in Series B - LumiThera
RPR Venture
RPR Venture investment in Series B - LumiThera
Official Site Inspections
http://www.lumithera.com Semrush global rank: 6.45 M Semrush visits lastest month: 1,000
- Host name: saber.ebox.co.nz
- IP address: 202.89.59.183
- Location: New Zealand
- Latitude: -41
- Longitude: 174
- Timezone: Pacific/Auckland
More informations about "LumiThera"
LumiThera 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for LumiThera. Use the PitchBook Platform to explore the full profile. See details»
LumiThera - Crunchbase Company Profile & Funding
LumiThera is a medical device company focused on LED and laser treatments for acute and chronic ocular disease. See details»
LumiThera Company Profile - Office Locations, Competitors ... - Craft
LumiThera has 5 employees across 3 locations and $29.83 m in total funding,. See insights on LumiThera including office locations, competitors, revenue, financials, executives, subsidiaries … See details»
LumiThera, Inc. Announces Creation of a Light-based ... - Newswire
Nov 11, 2021 LumiThera is a commercial-stage medical device company focused on treating people affected by ocular damage and disease including dry age-related macular degeneration, a … See details»
Alcon to Acquire LumiThera | Retinal Physician
5 days ago Alcon to Acquire LumiThera Centerpiece of the deal is the Valeda Light Delivery System, a photobiomodulation device that targets early and intermediate dry AMD. See details»
Alcon to acquire LumiThera and its photobiomodulation device for …
4 days ago Alcon will acquire LumiThera, including its photobiomodulation device for early and intermediate dry age-related macular degeneration, according to a press release. See details»
Alcon to acquire LumiThera and its photobiomodulation device for …
4 days ago Alcon’s acquisition of LumiThera includes a PBM device for early and intermediate dry AMD, enhancing its non-invasive treatment portfolio. LumiThera’s PBM device demonstrated … See details»
Alcon to Acquire LumiThera and Its Photobiomodulation Device for …
About LumiThera LumiThera, Inc. is an ophthalmic medical device company that is Harnessing the Power of Lightâ„¢ to offer a comprehensive approach for detecting, treating, and monitoring retinal … See details»
Alcon to Acquire LumiThera and Its Photobiomodulation Device for …
5 days ago LumiThera, Inc. is an ophthalmic medical device company that is Harnessing the Power of Lightâ„¢ to offer a comprehensive approach for detecting, treating, and monitoring retinal … See details»
LumiThera - Funding, Financials, Valuation & Investors
LumiThera is a medical device company focused on LED and laser treatments for acute and chronic ocular disease. See details»
Team – LumiThera
The Valeda Light Delivery System is intended to provide improved visual acuity in patients with best-corrected visual acuity of 20/32 through 20/70 and who have dry age-related macular … See details»
Contact – LumiThera
Contact LumiThera for more information. As a precaution, patients have not been tested and should not be treated with Valeda if they have any known photosensitivity to yellow light, red light, or … See details»
LumiThera - Financial Details - Crunchbase
LumiThera is a medical device company focused on LED and laser treatments for acute and chronic ocular disease. See details»
LumiThera, Inc. Announces Completion of Diopsys, Inc. Acquisition
SEATTLE, March 3, 2022 /PRNewswire/ — LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today … See details»
News – LumiThera
News LumiThera is a global ophthalmic medical device company offering a comprehensive portfolio for detecting, treating, and monitoring retinal diseases, particularly dry age-related macular … See details»
Photobiomodulation Treatment for Dry AMD Approved By FDA ...
Nov 15, 2024 The Valeda ® Light Delivery System (LumiThera, Inc.) is the first ever FDA-authorized treatment for vision loss in dry AMD, the manufacturer reported. The technology was … See details»
Alcon to Acquire LumiThera and Its Photobiomodulation Device for …
5 days ago LumiThera, Inc. is an ophthalmic medical device company that is Harnessing the Power of Lightâ„¢ to offer a comprehensive approach for detecting, treating, and monitoring retinal … See details»
Alcon to Acquire LumiThera, Maker of Photobiomodulation Device …
5 days ago According to Alcon, LumiThera’s PBM is the only device that has demonstrated meaningful vision improvement compared to baseline for people living with early to intermediate … See details»
Alcon to Acquire LumiThera and Its Photobiomodulation Device for …
5 days ago LumiThera, Inc. is an ophthalmic medical device company that is Harnessing the Power of Lightâ„¢ to offer a comprehensive approach for detecting, treating, and monitoring retinal … See details»
Alcon to acquire LumiThera for dry AMD treatment device
5 days ago Alcon (ALC) Monday announced its intention to acquire LumiThera and its PBM device for the treatment of early and intermediate dry AMD. See details»